Cite
HARVARD Citation
Noble, D. et al. (2022). Defining Biochemical Cure After Low Dose Rate Prostate Brachytherapy: External Validation of 4-year Prostate-specific Antigen Nadir as a Predictor of 10- and 15-year Disease-free Survival. Clinical oncology. 34 (1), pp. 42-49. [Online].